VTRS News and Press, Viatris Inc. From 11/13/23

Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI® (revefenacin) Phase III Trial in China for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) PR Newswire Top-line results from Phase III study in China demonstrate the effica...

2023-11-09 23:34:44 ET Summary Davis Selected Advisers' 13F portfolio decreased by 3% to $15.95B this quarter. The top three holdings in the portfolio are Meta Platforms, Berkshire Hathaway, and Wells Fargo. A new stake was established in MGM Resorts International, while stake...

2023-11-07 21:37:12 ET Viatris Inc. (VTRS) Q3 2023 Earnings Conference Call November 7, 2023, 05:00 PM ET Company Participants William Szablewski - Head of Global Capital Markets Scott Smith - CEO Rajiv Malik - President Sanjeev Narula - CFO David Bayles ...

2023-11-07 17:03:37 ET More on Viatris Full Viatris earnings info Viatris: Get Paid 5%, Before Growth Materializes Viatris' Survival Guide: Strategic Divestitures And Margins Viatris: Generic Semaglutide Could Become The Poor Man's Opt...

2023-11-07 16:05:04 ET More on Viatris Viatris: Get Paid 5%, Before Growth Materializes Viatris' Survival Guide: Strategic Divestitures And Margins Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss AbbVie, GSK, Teva cited as FTC ...

Viatris Reports Strong Financial and Operational Results for the Third Quarter 2023 and Reaffirms Full-Year 2023 Adjusted EBITDA and Free Cash Flow Guidance Ranges[1] PR Newswire Reports Total Revenues of $3.94 Billion ; U.S. GAAP Net Earnings of $332 Million ; Adjus...

2023-11-07 12:53:17 ET More on AbbVie, GSK, etc. Arexvy Puts GSK Back On The Growth Prescription (Rating Upgrade) GSK plc (GSK) Q3 2023 Earnings Call Transcript GSK plc 2023 Q3 - Results - Earnings Call Presentation J&J’s patent win against Viatris...

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

Viatris Inc. (VTRS) is expected to report $0.74 for Q3 2023

2023-11-06 15:44:53 ET Summary The iShares U.S. Pharmaceuticals ETF provides targeted exposure to the U.S. pharmaceutical industry but has a highly concentrated portfolio. The IHE ETF's top five holdings, including Eli Lilly and Johnson & Johnson, account for over 63% of the f...